Mckesson (MCK) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $998.64, +2.26% vs the prior close of $976.57.
- Volume 728.50K shares, 0.8x its 50-day average.
- New SEC filings: 144 (Oct 15, 2026).
- No new insider buys or sales reported since the prior session.
MCK rises 2.3% to $998.64, a 52-week high, 6 up days in a row. Closed at $998.64, +2.26% vs the prior close of $976.57. Day range $988.61–$1,003.21, opened at $995.80.
MCK daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — MCK rises 2.3% to $998.64, a 52-week high, 6 up days in a row
- Closed at $998.64, +2.26% vs the prior close of $976.57. Day range $988.61–$1,003.21, opened at $995.80.
- Volume was 728.50K shares, 0.8x its 50-day average of 893.78K.
- Price is +11.7% vs its 50-day average ($893.76) and +17.1% vs its 200-day average ($853.09).
- 52-week range $723.68–$1,003.21; today's close sits at 98% of that range, 0.5% below the 52-week high.
- That makes 6 straight gains.
Oct 14, 2026 — MCK rises 1.5% to $976.57, a 6-month high, 5 up days in a row
- Closed at $976.57, +1.53% vs the prior close of $961.88. Day range $965.05–$979.82, opened at $968.07.
- Volume was 767.90K shares, 0.9x its 50-day average of 900.21K.
- Price is +9.6% vs its 50-day average ($891.33) and +14.6% vs its 200-day average ($852.24).
- 52-week range $723.68–$999.00; today's close sits at 92% of that range, 2.2% below the 52-week high.
- That makes 5 straight gains.
Oct 13, 2026 — MCK rises 0.6% to $961.88, a 6-month high, 4 up days in a row
- Closed at $961.88, +0.64% vs the prior close of $955.76. Day range $954.18–$969.48, opened at $963.42.
- Volume was 743.60K shares, 0.8x its 50-day average of 914.13K.
- Price is +8.3% vs its 50-day average ($888.41) and +13.0% vs its 200-day average ($851.50).
- 52-week range $723.68–$999.00; today's close sits at 87% of that range, 3.7% below the 52-week high.
- That makes 4 straight gains.
Oct 12, 2026 — MCK rises 1.8% to $955.76, a 6-month high, 3 up days in a row
- Closed at $955.76, +1.80% vs the prior close of $938.84. Day range $936.77–$956.24, opened at $949.95.
- Volume was 646.90K shares, 0.7x its 50-day average of 916.66K.
- Price is +7.9% vs its 50-day average ($885.71) and +12.3% vs its 200-day average ($850.83).
- 52-week range $723.68–$999.00; today's close sits at 84% of that range, 4.3% below the 52-week high.
- That makes 3 straight gains.
Oct 9, 2026 — MCK rises 0.9% to $938.84, a 6-month high
- Closed at $938.84, +0.92% vs the prior close of $930.25. Day range $925.00–$943.97, opened at $927.56.
- Volume was 482.90K shares, 0.5x its 50-day average of 926.80K — lighter than usual.
- Price is +6.2% vs its 50-day average ($883.72) and +10.4% vs its 200-day average ($850.18).
- 52-week range $723.68–$999.00; today's close sits at 78% of that range, 6.0% below the 52-week high.
Oct 8, 2026 — MCK rises 2.2% to $930.25, a 6-month high
- Closed at $930.25, +2.19% vs the prior close of $910.33. Day range $906.65–$938.51, opened at $906.65.
- Volume was 715.60K shares, 0.8x its 50-day average of 929.25K.
- Price is +5.4% vs its 50-day average ($882.26) and +9.5% vs its 200-day average ($849.57).
- 52-week range $723.68–$999.00; today's close sits at 75% of that range, 6.9% below the 52-week high.
Oct 7, 2026 — MCK dips 1.2% to $910.33
- Closed at $910.33, -1.23% vs the prior close of $921.67. Day range $908.49–$933.99, opened at $924.21.
- Volume was 794.40K shares, 0.8x its 50-day average of 945.40K.
- Price is +3.3% vs its 50-day average ($881.42) and +7.2% vs its 200-day average ($849.02).
- 52-week range $723.68–$999.00; today's close sits at 68% of that range, 8.9% below the 52-week high.
Oct 6, 2026 — MCK rises 0.7% to $921.67, a 1-month high, 4 up days in a row
- Closed at $921.67, +0.68% vs the prior close of $915.45. Day range $914.23–$928.46, opened at $921.00.
- Volume was 680.50K shares, 0.7x its 50-day average of 947.79K.
- Price is +4.6% vs its 50-day average ($881.01) and +8.6% vs its 200-day average ($848.52).
- 52-week range $723.68–$999.00; today's close sits at 72% of that range, 7.7% below the 52-week high.
- That makes 4 straight gains.
- SEC filings that day: 8-K.
Oct 5, 2026 — MCK rises 1.5% to $915.45, 3 up days in a row
- Closed at $915.45, +1.46% vs the prior close of $902.28. Day range $900.72–$922.46, opened at $905.22.
- Volume was 697.60K shares, 0.7x its 50-day average of 950.31K.
- Price is +4.1% vs its 50-day average ($879.57) and +8.0% vs its 200-day average ($847.95).
- 52-week range $723.68–$999.00; today's close sits at 70% of that range, 8.4% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 — MCK rises 0.4% to $902.28
- Closed at $902.28, +0.38% vs the prior close of $898.82. Day range $881.40–$905.55, opened at $899.02.
- Volume was 777.00K shares, 0.8x its 50-day average of 949.88K.
- Price is +2.8% vs its 50-day average ($878.08) and +6.5% vs its 200-day average ($847.42).
- 52-week range $723.68–$999.00; today's close sits at 65% of that range, 9.7% below the 52-week high.
MCK latest news & SEC filings
Every SEC filing by or about MCK in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 15, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Oct 6, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Sep 10, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Rutledge Napoleon B Jr sold 111 shares at $891.45 (≈$98.95K) on Sep 8, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 28, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 11, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Lerman Bradley E sold 301 shares at $892.33 (≈$268.59K) on Aug 10, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Aug 10, 2026 · 3 — Initial insider ownership statement (Form 3)
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Aug 10, 2026 · 144 — Notice of proposed sale (Form 144)
Notice of proposed sale (Form 144) — an insider or affiliate plans to sell restricted or control shares
A notice of intent, not a completed sale. Any actual sale by a director or officer shows up later on Form 4.
Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $105.38B (prior year $97.83B) (+7.7% vs Jun 30, 2025)
- Net income: $614.00M (prior year $784.00M) (-21.7% vs Jun 30, 2025)
- Diluted EPS: $5.15 (prior year $6.25) (-17.6% vs Jun 30, 2025)
Aug 5, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Jul 1, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Jun 30, 2026 · DEFA14A — Additional proxy materials
Additional proxy materials
Things to know before you trade MCK
- Last results release: Aug 5, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 4, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.35% (largest 5.3%).
- Liquidity: about 813.20K shares (≈$812.09M) trade per day on average.
- 52-week position: $998.64 vs a range of $723.68–$1,003.21 (98% of the range).
- Dividends: last ex-dividend date Sep 1, 2026 ($0.94/share); 4 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 18 sales; latest: Napoleon B Jr Rutledge sold 111 shares on Sep 8, 2026.
- Latest filings: 8-K Oct 6, 2026; 8-K Aug 28, 2026; 10-Q Aug 5, 2026.
- Share count: 116.59M shares outstanding (Jul 31, 2026), -6.3% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Wholesale-Drugs, Proprietaries & Druggists' Sundries.
MCK market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 995.80 | 1,003.21 | 988.61 | 998.64 | 728.50K |
| Oct 14, 2026 | 968.07 | 979.82 | 965.05 | 976.57 | 767.90K |
| Oct 13, 2026 | 963.42 | 969.48 | 954.18 | 961.88 | 743.60K |
| Oct 12, 2026 | 949.95 | 956.24 | 936.77 | 955.76 | 646.90K |
| Oct 9, 2026 | 927.56 | 943.97 | 925.00 | 938.84 | 482.90K |
| Oct 8, 2026 | 906.65 | 938.51 | 906.65 | 930.25 | 715.60K |
| Oct 7, 2026 | 924.21 | 933.99 | 908.49 | 910.33 | 794.40K |
| Oct 6, 2026 | 921.00 | 928.46 | 914.23 | 921.67 | 680.50K |
| Oct 5, 2026 | 905.22 | 922.46 | 900.72 | 915.45 | 697.60K |
| Oct 2, 2026 | 899.02 | 905.55 | 881.40 | 902.28 | 777.00K |
| Oct 1, 2026 | 886.47 | 924.21 | 881.34 | 898.82 | 1.21M |
| Sep 30, 2026 | 862.26 | 866.19 | 847.30 | 853.81 | 691.20K |
| Sep 29, 2026 | 849.29 | 866.44 | 847.29 | 864.82 | 476.90K |
| Sep 28, 2026 | 865.02 | 871.20 | 855.64 | 856.29 | 550.00K |
| Sep 25, 2026 | 865.00 | 871.00 | 858.76 | 866.64 | 452.00K |
| Sep 24, 2026 | 883.02 | 896.60 | 866.59 | 869.36 | 593.50K |
| Sep 23, 2026 | 889.79 | 907.07 | 880.50 | 880.50 | 672.90K |
| Sep 22, 2026 | 891.11 | 897.57 | 882.88 | 891.23 | 935.70K |
| Sep 21, 2026 | 874.79 | 895.34 | 873.35 | 886.47 | 940.30K |
| Sep 18, 2026 | 872.78 | 881.05 | 864.12 | 874.65 | 2.71M |
About Mckesson
Mckesson (MCK) is listed on the NYSE and classified by the SEC under “Wholesale-Drugs, Proprietaries & Druggists' Sundries”. Its business address is in IRVING, TX. State of incorporation: DE. Fiscal year ends March 31. SEC CIK 927653.
MCK board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Dominic J Caruso | Director | Jul 23, 2026 |
| Lynne M Doughtie | Director | Jul 23, 2026 |
| Webster Roy Dunbar | Director | Jul 23, 2026 |
| Deborah Dunsire | Director | Jul 23, 2026 |
| Julie L. Gerberding | Director | Jul 23, 2026 |
| James H. Hinton | Director | Jul 23, 2026 |
| Bradley E Lerman | Director | Aug 11, 2026 |
| Maria Martinez | Director | Jul 23, 2026 |
| Kevin M Ozan | Director | Jul 23, 2026 |
| Brian S. Tyler | Chief Executive Officer | Jul 8, 2026 |
| Kathleen Wilson-Thompson | Director | Jul 23, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Kenny K Cheung | EVP & CFO | Jun 1, 2026 |
| Francisco Fraga | EVP, CIO and CTO | May 27, 2026 |
| Michele Lau | EVP and Chief Legal Officer | May 27, 2026 |
| Thomas L Rodgers | EVP, Chief Strategy & BDO | Jun 3, 2026 |
| Napoleon B Jr Rutledge | SVP, Controller & CAO | Sep 10, 2026 |
| Leann B Smith | EVP & Chief HR Officer | Jun 2, 2026 |
| Ramesh (Nmn) Srinivasan | EVP and Chief Strategy Officer | Aug 11, 2026 |
| Brian S. Tyler | Chief Executive Officer | Jul 8, 2026 |
| Britt J. Vitalone | EVP & CFO | May 27, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 8, 2026 | Napoleon B Jr Rutledge | Sale | 111 | $891.45 |
| Aug 10, 2026 | Bradley E Lerman | Sale | 301 | $892.33 |
| Jul 7, 2026 | Brian S. Tyler | Sale | 8,463 | $793.56 |
| Jun 17, 2026 | Brian S. Tyler | Sale | 8,463 | $775.13 |
| Jun 9, 2026 | Brian S. Tyler | Sale | 4,929 | $763.00 |
| Jun 5, 2026 | Napoleon B Jr Rutledge | Sale | 133 | $764.00 |
| Jun 2, 2026 | Thomas L Rodgers | Sale | 699 | $735.27 |
| Jun 1, 2026 | Thomas L Rodgers | Sale | 123 | $735.50 |
| Jun 1, 2026 | Leann B Smith | Sale | 1,810 | $735.50 |
| May 26, 2026 | Michele Lau | Sale | 3,550 | $761.09 |
| May 26, 2026 | Thomas L Rodgers | Sale | 2,388 | $761.09 |
| Mar 2, 2026 | Michele Lau | Sale | 2,725 | $990.00 |
| Feb 19, 2026 | Maria Martinez | Sale | 349 | $939.87 |
| Feb 17, 2026 | Leann B Smith | Sale | 190 | $945.00 |
| Feb 11, 2026 | Michele Lau | Sale | 303 | $933.39 |
MCK financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Mar 31, 2026 | $403.43B | $4.76B | — | $6.16B |
| Mar 31, 2025 | $359.05B | $3.29B | — | $6.08B |
| Mar 31, 2024 | $308.95B | $3.00B | — | $4.31B |
| Mar 31, 2023 | $276.71B | $3.56B | — | $5.16B |
| Mar 31, 2022 | $263.97B | $1.11B | — | $4.43B |
Latest balance sheet: total assets $88.33B, total liabilities $—, cash $5.16B (as of Jun 30, 2026).
MCK earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 5, 2026 | 8-K Item 2.02 (results) | $877.23 |
| May 7, 2026 | 8-K Item 2.02 (results) | $754.76 |
| Feb 4, 2026 | 8-K Item 2.02 (results) | $822.00 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $844.26 |
| Sep 18, 2025 | 8-K Item 2.02 (results) | $690.13 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $703.76 |
| May 8, 2025 | 8-K Item 2.02 (results) | $690.25 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $606.90 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $549.31 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 7, 2024 | 8-K Item 2.02 (results) | — |
| Feb 7, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cencora (COR)Cardinal Health (CAH)Herbalife (HLF)Nu Skin Enterprises (NUS)Cosmos Health (COSM)DataMeds AI (MEDS)Cellyan Biotechnology (HKPD)HWH International (ESYN)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on MCK
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.